[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364277-105":59,"doc-detail-364277-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-analysis-of-inhibin-a-as-a-potential-biomarker-for-gastrointestinal-tract-cancers-through-bioinformatics-approaches","Comprehensive analysis of inhibin-β A as a potential biomarker for gastrointestinal tract cancers through bioinformatics approaches","","Bioinformatics analysis evaluates inhibin-β A (INHBA), encoding a TGF-β superfamily protein, as a candidate biomarker across gastrointestinal (GI) tract cancers. Using GEPIA2 with TCGA transcriptomic data and GTEx normals, INHBA shows consistent upregulation in most TCGA GI tumors except liver hepatocellular carcinoma, where expression is reduced. Expression differences associate with tumor stages and prognosis, including poorer overall survival and disease-free survival in specific GI subtypes. The study links INHBA alterations to mutations/amplifications, DNA methylation, immune infiltration, functional enrichment, KEGG pathway involvement, and survival outcomes, including positive correlation with cancer-associated fibroblasts, supporting therapeutic targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-analysis-of-inhibin-a-as-a-potential-biomarker-for-gastrointestinal-tract-cancers-through-bioinformatics-approaches/364277/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-inhibin-a-as-a-potential-biomarker-for-gastrointestinal-tract-cancers-through-bioinformatics-approaches/364277.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does INHBA expression differ across gastrointestinal tract cancers in TCGA data?","Question",{"text":112,"@type":113},"INHBA is consistently upregulated across most TCGA GI tract cancers, except liver hepatocellular carcinoma, where it is downregulated versus normal tissues (including GTEx normals).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which GI cancer types show significant INHBA expression differences?",{"text":117,"@type":113},"Significant differences are reported in adenocarcinomas of the colon, pancreas, rectum, and stomach, while cholangiocarcinoma and liver cancer do not show such differences.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence links INHBA to prognosis and potential biomarker use?",{"text":121,"@type":113},"Expression differences correlate with pathological tumor stages and prognosis. INHBA shows worse overall survival in colon and stomach cancers and worse disease-free survival in colon and pancreatic adenocarcinoma, with additional links to methylation, immune infiltration, and fibroblast correlation, supporting biomarker and therapeutic targeting potential.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364277,1790210828,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nComprehensive analysis of inhibin-β A as a potential biomarker for gastrointestinal tract cancers through bioinformatics approaches  \nRohit Kumar Verma1, Prashant Kumar Srivastava2􀀍 & Ashutosh Singh1􀀍  \nInhibin, β, which is also known as INHBA, encodes a protein that belongs to the Transforming Growth factor-β (TGF-β) superfamily, which plays a pivotal role in cancer. Gastrointestinal tract (GI tract) cancer refers to the cancers that develop in the colon, liver, esophagus, stomach, rectum, pancreas, and bile ducts ofthe digestive system. The role of INHBA in all GI tract cancers remains understudied. By utilizing GEPIA2, which uses transcriptomic data from TCGA, we examined the expression of INHBA across different GI tract cancers. The results revealed consistent upregulation of INHBA in all TCGA GI tract cancers, except for liver hepatocellular carcinoma, where it showed downregulation compared to normal tissues, along with GTEx normal samples. Significant differences in INHBA expression were noted in adenocarcinomas ofthe colon, pancreas, rectum, and stomach, while no such differences were observed in cholangiocarcinoma and liver cancer. Moreover, a comprehensive bioinformatics analysis has been done to demonstrate that the differences in expression levels are significantly related to pathological tumor stages and prognosis in different GI tract cancers. Mucinous adenocarcinoma, esophageal squamous cell carcinoma, and stomach adenocarcinoma show a higher frequency of INHBA alteration and are primarily linked to mutations and amplifications. DNA methylation, immune infiltration, functional enrichment analysis, the genes associated with INHBA, and survival analysis in all TCGA GI tract cancers have been extensively analyzed. In colon and stomach cancers, increased INHBA expression significantly correlates with poorer overall survival (OS) . However, in colon and pancreatic adenocarcinoma, higher expression is significantly associated with worse disease-free survival (DFS). Additionally, INHBA expression exhibited a positive correlation with cancer-associated fibroblasts across all gastrointestinal (GI) tract cancers. The KEGG pathway analysis revealed that INHBA and its interacting proteins are involved in several pathways, including TGF-beta signaling, Signalling pathways regulating pluripotency of stem cells, colorectal cancer, pancreatic cancer, AGERAGE signaling, and so on as major pathways. These findings demonstrate that INHBA could serve as a potential biomarker therapeutic target for GI tract cancer.  \nKeywords INHBA Inhibin-β A, Transforming growth factor-β, Gastrointestinal tract cancers, Prognostic biomarker, DNA methylation  \nAbbreviations  \nINHBA Inhibin subunit beta AGI Gastrointestinal  \nCPTAC Clinical Proteomic Tumor Analysis Consortium BP Biological process  \nCC Cellular component  \nDFS Disease-free survival  \nGEPIA Gene expression profiling interactive analysis GO Gene ontology  \nKEGG Kyoto encyclopedia of genes and genomes GTEx Genotype-tissue expression  \n1Department of Life Sciences, School of Natural Sciences (SONS), Shiv Nadar Institution of Eminence, Delhi NCR, India. 2National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK. 􀀍 email: [prashant.srivastava@imperial.ac.uk](prashant.srivastava@imperial.ac.uk); [ashutosh.singh@snu.edu.in](ashutosh.singh@snu.edu.in)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nTIMER Tumor immune estimation resource  \nAA Amino acid  \nACC Adrenocortical carcinoma  \nBLCA Bladder Urothelial Carcinoma  \nBRCA Breast invasive carcinoma  \nCESC Cervical squamous cell carcinoma and endocervical adenocarcinoma DLBC Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  \nGBM Glioblastoma multiforme  \nHNSC Head and Neck squamous cell carcinoma KICH Kidney Chromophobe  \nKIRC Kidney renal clear cell carcinoma KIRP Kidney renal papillary cell carcinom","cbCaivKhj16jStta","https://ap.wps.com/l/cbCaivKhj16jStta","pdf",13494029,21,"English","# Background and rationale\n## INHBA identity and role in cancer\n## GI tract cancer scope and unmet need\n# Methods and data sources\n## GEPIA2, TCGA expression profiling, and GTEx comparison\n## Additional bioinformatics analyses\n# Key findings\n## INHBA expression patterns across GI cancers\n## Association with tumor stage and prognosis\n## Genomic alterations and methylation links\n## Immune infiltration and functional enrichment\n# Pathway and biomarker implications\n## KEGG pathway involvement\n## Therapeutic biomarker potential\n# Abbreviations and glossary","[{\"question\":\"How does INHBA expression differ across gastrointestinal tract cancers in TCGA data?\",\"answer\":\"INHBA is consistently upregulated across most TCGA GI tract cancers, except liver hepatocellular carcinoma, where it is downregulated versus normal tissues (including GTEx normals).\"},{\"question\":\"Which GI cancer types show significant INHBA expression differences?\",\"answer\":\"Significant differences are reported in adenocarcinomas of the colon, pancreas, rectum, and stomach, while cholangiocarcinoma and liver cancer do not show such differences.\"},{\"question\":\"What evidence links INHBA to prognosis and potential biomarker use?\",\"answer\":\"Expression differences correlate with pathological tumor stages and prognosis. INHBA shows worse overall survival in colon and stomach cancers and worse disease-free survival in colon and pancreatic adenocarcinoma, with additional links to methylation, immune infiltration, and fibroblast correlation, supporting biomarker and therapeutic targeting potential.\"}]","Comprehensive analysis of inhibin-β A as a potential biomarker for gastrointestinal tract cancers through bioinformatics approaches | PDF",1790156688,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81ff5edf1a9d4664be39375a1bb2a5de.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a73f4811ce3c53a432ad5d2bbf33d46.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1364df9cd41e1ec8d3a574c847d911d3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3da9677483e8702ac5b5d6340583651.webp",980,1287]